Sabine Hermans1,2,3, Morna Cornell4, Keren Middelkoop1,5, Robin Wood1,5,6. 1. Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa. 2. Department of Global Health, Academic Medical Center, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, The Netherlands. 3. Department of Internal Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. 4. Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. 5. Department of Medicine, University of Cape Town, Cape Town, South Africa. 6. Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Abstract
OBJECTIVE: To assess the impact of the HIV epidemic and the rollout of antiretroviral therapy (ART) from 2004 on the gender-specific TB burden in Cape Town, we investigated temporal changes in TB notification rates, the HIV-associated relative risk of TB and the population attributable risk fraction (PAF) of HIV by gender. METHODS: Annual TB notifications, mid-year population and HIV prevalence estimates were used to calculate rates per 100 000 population stratified by gender and HIV. Annual rate ratios (RR) of TB associated with HIV and PAF were calculated by gender. RESULTS: Pre-HIV TB notification rates were lower among women than men (146/100 000 vs. 247/100 000). With the onset of the HIV, epidemic rates increased 5.3-fold in women (to 778/100 000) and 3.7-fold in men (to 917/100 000) to a peak in 2008, after which they declined by 25% in women (to 634/100 000) and 18% in men (to 755/100 000) by 2014. The HIV-associated RR of TB was 25% higher in women than in men in 2006 (25 vs. 20), but decreased to the same level in 2014. HIV PAF declined between 2008 and 2014 from 56% to 50% and from 40% to 38% in women and men, respectively. CONCLUSIONS: The HIV epidemic led to greater relative increases in TB rates among women than men. The increased HIV-associated TB risk in women could be compatible with removal of the biological protection of female gender by HIV infection. The decline in RR and PAF in HIV-positive women could be explained by increasing ART usage reversing female gender-related susceptibility.
OBJECTIVE: To assess the impact of the HIV epidemic and the rollout of antiretroviral therapy (ART) from 2004 on the gender-specific TB burden in Cape Town, we investigated temporal changes in TB notification rates, the HIV-associated relative risk of TB and the population attributable risk fraction (PAF) of HIV by gender. METHODS: Annual TB notifications, mid-year population and HIV prevalence estimates were used to calculate rates per 100 000 population stratified by gender and HIV. Annual rate ratios (RR) of TB associated with HIV and PAF were calculated by gender. RESULTS: Pre-HIV TB notification rates were lower among women than men (146/100 000 vs. 247/100 000). With the onset of the HIV, epidemic rates increased 5.3-fold in women (to 778/100 000) and 3.7-fold in men (to 917/100 000) to a peak in 2008, after which they declined by 25% in women (to 634/100 000) and 18% in men (to 755/100 000) by 2014. The HIV-associated RR of TB was 25% higher in women than in men in 2006 (25 vs. 20), but decreased to the same level in 2014. HIV PAF declined between 2008 and 2014 from 56% to 50% and from 40% to 38% in women and men, respectively. CONCLUSIONS: The HIV epidemic led to greater relative increases in TB rates among women than men. The increased HIV-associated TB risk in women could be compatible with removal of the biological protection of female gender by HIV infection. The decline in RR and PAF in HIV-positive women could be explained by increasing ART usage reversing female gender-related susceptibility.
Keywords:
Afrique subsaharienne; disease notification; epidemiology; gender; incidence; notification de la maladie; rapport des sexes; sex; sex ratio; sexe; sub-Saharan Africa; tuberculosis; épidémiologie
Authors: Stephen D Lawn; Robin Wood; Kevin M De Cock; Katharina Kranzer; James J Lewis; Gavin J Churchyard Journal: Lancet Infect Dis Date: 2010-07 Impact factor: 25.071
Authors: A C Crampin; J R Glynn; S Floyd; S S Malema; V K Mwinuka; B M M Ngwira; F D Mwaungulu; D K Warndorff; P E M Fine Journal: Int J Tuberc Lung Dis Date: 2004-02 Impact factor: 2.373
Authors: Andrew F Auld; Ray W Shiraishi; Francisco Mbofana; Aleny Couto; Ernest Benny Fetogang; Shenaaz El-Halabi; Refeletswe Lebelonyane; Pilatwe Tlhagiso Pilatwe; Ndapewa Hamunime; Velephi Okello; Tsitsi Mutasa-Apollo; Owen Mugurungi; Joseph Murungu; Janet Dzangare; Gideon Kwesigabo; Fred Wabwire-Mangen; Modest Mulenga; Sebastian Hachizovu; Virginie Ettiegne-Traore; Fayama Mohamed; Adebobola Bashorun; Do Thi Nhan; Nguyen Huu Hai; Tran Huu Quang; Joelle Deas Van Onacker; Kesner Francois; Ermane G Robin; Gracia Desforges; Mansour Farahani; Harrison Kamiru; Harriet Nuwagaba-Biribonwoha; Peter Ehrenkranz; Julie A Denison; Olivier Koole; Sharon Tsui; Kwasi Torpey; Ya Diul Mukadi; Eric van Praag; Joris Menten; Timothy D Mastro; Carol Dukes Hamilton; Oseni Omomo Abiri; Mark Griswold; Edna Pierre; Carla Xavier; Charity Alfredo; Kebba Jobarteh; Mpho Letebele; Simon Agolory; Andrew L Baughman; Gram Mutandi; Peter Preko; Caroline Ryan; Trong Ao; Elizabeth Gonese; Amy Herman-Roloff; Kunomboa A Ekra; Joseph S Kouakou; Solomon Odafe; Dennis Onotu; Ibrahim Dalhatu; Henry H Debem; Duc B Nguyen; Le Ngoc Yen; Abu S Abdul-Quader; Valerie Pelletier; Seymour G Williams; Stephanie Behel; George Bicego; Mahesh Swaminathan; E Kainne Dokubo; Georgette Adjorlolo-Johnson; Richard Marlink; David Lowrance; Thomas Spira; Robert Colebunders; David Bangsberg; Aaron Zee; Jonathan Kaplan; Tedd V Ellerbrock Journal: MMWR Morb Mortal Wkly Rep Date: 2015-11-27 Impact factor: 17.586
Authors: Adamson S Muula; Thabale J Ngulube; Seter Siziya; Cecilia M Makupe; Eric Umar; Hans Walter Prozesky; Charles S Wiysonge; Ronald H Mataya Journal: BMC Public Health Date: 2007-04-25 Impact factor: 3.295
Authors: Wei-Teng Yang; Celine R Gounder; Tokunbo Akande; Jan-Walter De Neve; Katherine N McIntire; Aditya Chandrasekhar; Alan de Lima Pereira; Naveen Gummadi; Santanu Samanta; Amita Gupta Journal: Tuberc Res Treat Date: 2014-04-28